Determination of C-reactive protein: comparison of three high-sensitivity immunoassays.
暂无分享,去创建一个
[1] W. Koenig,et al. Refinement of the association of serum C-reactive protein concentration and coronary heart disease risk by correction for within-subject variation over time: the MONICA Augsburg studies, 1984 and 1987. , 2003, American journal of epidemiology.
[2] M. Woodward,et al. Distributions of C-reactive protein measured by high-sensitivity assays in apparently healthy men and women from different populations in Europe. , 2003, Clinical chemistry.
[3] P. Ridker,et al. Population distributions of C-reactive protein in apparently healthy men and women in the United States: implication for clinical interpretation. , 2003, Clinical chemistry.
[4] P. Ridker. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. , 2003, Circulation.
[5] Yu-ling,et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. , 2003, Circulation.
[6] Nancy R Cook,et al. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. , 2002, The New England journal of medicine.
[7] M. V. van Dieijen-Visser,et al. High-sensitivity C-reactive protein methods examined. , 2002, Clinical chemistry.
[8] D. Rothenbacher,et al. Role of novel markers of inflammation in patients with stable coronary heart disease. , 2001, The American journal of cardiology.
[9] J. Danesh,et al. Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses , 2000, BMJ : British Medical Journal.
[10] G. Lowe,et al. Immunoradiometric assay of circulating C-reactive protein: age-related values in the adult general population. , 2000, Clinical chemistry.
[11] N. Rifai,et al. Evaluation of four automated high-sensitivity C-reactive protein methods: implications for clinical and epidemiological applications. , 2000, Clinical chemistry.
[12] N Rifai,et al. Clinical efficacy of an automated high-sensitivity C-reactive protein assay. , 1999, Clinical chemistry.
[13] K. Williams,et al. Atherosclerosis--an inflammatory disease. , 1999, The New England journal of medicine.
[14] A. Döring,et al. C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992. , 1999, Circulation.
[15] P. Ridker,et al. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. , 1997, The New England journal of medicine.
[16] D. Hosmer,et al. Applied Logistic Regression , 1991 .
[17] D. Altman,et al. STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT , 1986, The Lancet.
[18] M. Pepys,et al. Solid phase radioimmunoassays for human C-reactive protein. , 1981, Clinica chimica acta; international journal of clinical chemistry.
[19] Laurent Degos,et al. HISTOCOMPATIBILITY DETERMINANTS IN MULTIPLE SCLEROSIS , 1974 .
[20] N Rifai,et al. Proposed cardiovascular risk assessment algorithm using high-sensitivity C-reactive protein and lipid screening. , 2001, Clinical chemistry.
[21] R F Martin,et al. General deming regression for estimating systematic bias and its confidence interval in method-comparison studies. , 2000, Clinical chemistry.